2022 marks the 10th anniversary of our International Linked Clinical Trials (iLCT) programme. Since it was launched over 3,700 people have taken part in 2022 marks the 10th anniversary of this successful and pioneering drug repurposing programme for Parkinson’s.
— Read on cureparkinsons.org.uk/10-years-ilct/